Dequalinium™ vesicles form stable complexes with plasmid DNA which are protected from DNase attack

被引:34
作者
Lasch, J [1 ]
Meye, A
Taubert, H
Koelsch, R
Mansa-ard, J
Weissig, V
机构
[1] Univ Halle Wittenberg, Inst Physiol Chem, D-06097 Halle, Germany
[2] Univ Halle Wittenberg, Inst Pathol, D-06097 Halle, Germany
[3] Northeastern Univ, Bouve Coll Pharm, Boston, MA 02115 USA
关键词
antineoplastic DNA vehicle; bolaamphiphile; dequalinium; DNA; DNase-attack protection; DQA-complexes; DQAsomal gene transfer;
D O I
10.1515/BC.1999.080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upon sonication, the antimicrobial and antineoplastic compound dequaliniumTM forms vesicles (DQAsomes, Weissig et al,, 1998), DequaliniumTM (1,1'-(1,10-decamethylene-bis-[aminoquinaldinium])-chloride) was shown to be a fluorophore with an emission maximum at 366 nm, Addition of DNA results in a characteristic quenching of its intrinsic fluorescence. After density gradient centrifugation a band of dequaliniumTM (DQA) tightly associated with DNA is located between the DNA and DQA bands. DQA/DNA-complexes containing plasmid DNA at a molar ratio of DQA/DNA 6:1 are completely protected against DNase activity. Addition of negatively-charged lipids release intact DNA in the same manner as from cationic lipid/DNA complexes. As regards biological effects, DQAsomes show a differential cytotoxicity for normal and sarcoma cell lines. In vitro incubation with fluorescein-labeled oligodeoxynucleotides (5'-fiuorescein-[GATC](5)) showed an increased uptake of the tagged oligodeoxynucleotide if complexed with dequalinium. We hypothesize that the DQA/DNA complexes are well-suited for 'DQAsomal gene transfer' in vitro and in vivo. Noteworthy, they display an intrinsic antitumor activity manifested by differential cytotoxicity for normal and sarcoma cells.
引用
收藏
页码:647 / 652
页数:6
相关论文
共 13 条
[1]   SELECTIVE ANTIMITOCHONDRIAL AGENTS INHIBIT CALMODULIN [J].
BODDEN, WL ;
PALAYOOR, ST ;
HAIT, WN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 135 (02) :574-582
[2]   DEQUALINIUM - A POTENT INHIBITOR OF APAMIN-SENSITIVE K(+) CHANNELS IN HEPATOCYTES AND OF NICOTINIC RESPONSES IN SKELETAL-MUSCLE [J].
CASTLE, NA ;
HAYLETT, DG ;
MORGAN, JM ;
JENKINSON, DH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 236 (02) :201-207
[3]   STUDY OF THE SELECTIVE CYTOTOXIC PROPERTIES OF CATIONIC, LIPOPHILIC MITOCHONDRIAL-SPECIFIC COMPOUNDS IN GYNECOLOGIC MALIGNANCIES [J].
CHRISTMAN, JE ;
MILLER, DS ;
COWARD, P ;
SMITH, LH ;
TENG, NNH .
GYNECOLOGIC ONCOLOGY, 1990, 39 (01) :72-79
[4]   CLINICAL USEFULNESS OF CHEMOSENSITIVITY TESTING USING THE MTT ASSAY [J].
FURUKAWA, T ;
KUBOTA, T ;
SUTO, A ;
TAKAHARA, T ;
YAMAGUCHI, H ;
TAKEUCHI, T ;
KASE, S ;
KODAIRA, S ;
ISHIBIKI, K ;
KITAJIMA, M .
JOURNAL OF SURGICAL ONCOLOGY, 1991, 48 (03) :188-193
[5]   EFFECT OF DESQUALINIUM ON K1735-M2 MELANOMA CELL-GROWTH, DIRECTIONAL MIGRATION AND INVASION INVITRO [J].
HELIGE, C ;
SMOLLE, J ;
ZELLNIG, G ;
FINKPUCHES, R ;
KERL, H ;
TRITTHART, HA .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) :124-128
[6]  
LEATHERBARROW RJ, 1992, GRAFIT USERS GUIDE V
[7]  
MORIYAMA Y, 1995, FEBS LETT, V6, P69
[8]  
NEW RRC, 1989, LIPOSOMES PRACTICAL, P95
[9]  
ROTENBERG SA, 1990, CANCER RES, V50, P677
[10]  
SWEET S, 1995, CANCER RES, V55, P5164